1. Academic Validation
  2. Macrolide Inspired Macrocycles as Modulators of the IL-17A/IL-17RA Interaction

Macrolide Inspired Macrocycles as Modulators of the IL-17A/IL-17RA Interaction

  • J Med Chem. 2021 Jun 24;64(12):8354-8383. doi: 10.1021/acs.jmedchem.1c00327.
Sanja Koštrun 1 Andrea Fajdetić 1 Dijana Pešić 1 Karmen Brajša 1 Vlatka Bencetić Mihaljević 1 Dubravko Jelić 1 Adriana Petrinić Grba 1 Ivaylo Elenkov 1 Renata Rupčić 1 Samra Kapić 1 Ivana Ozimec Landek 1 Kristina Butković 1 Ana Grgičević 1 Dinko Žiher 1 Ana Čikoš 1 Jasna Padovan 1 Gordon Saxty 1 Kevin Dack 2 Haakan Bladh 2 Tine Skak-Nielsen 2 Simon Feldbaek Nielsen 2 Maja Lambert 2 Martin Stahlhut 2
Affiliations

Affiliations

  • 1 Fidelta Ltd, Prilaz baruna Filipovića 29, 10000 Zagreb, Croatia.
  • 2 LEO Pharma A/S, Industriparken 55, 2750 Ballerup, Denmark.
Abstract

Interleukin 17 (IL-17) cytokines promote inflammatory pathophysiology in many autoimmune diseases, including psoriasis, multiple sclerosis, rheumatoid arthritis, and inflammatory bowel disease. Such broad involvement of IL-17 in various autoimmune diseases makes it an ideal target for drug discovery. Psoriasis is a chronic inflammatory disease characterized by numerous defective components of the immune system. Significantly higher levels of IL-17A have been noticed in lesions of psoriatic patients, if compared to non-lesion parts. Therefore, this paper is focused on the Macrolide inspired macrocycles as potential IL-17A/IL-17RA modulators and covers the molecular design, synthesis, and in vitro profiling. Macrocycles are designed to diversify and enrich chemical space through different ring sizes and a variety of three-dimensional shapes. Inhibitors in the nM range were identified in both target-based and phenotypic assays. In vitro ADME as well as in vivo PK properties are reported.

Figures